SkinBioTherapeutics plc (AIM: SBTX), shares fell around 30% after the skin health-focused life sciences company announced the resignation of its chief executive officer, Stuart Ashman.
SkinBioTherapeutics plc (AIM: SBTX), shares fell around 30% after the skin health-focused life sciences company announced the resignation of its chief executive officer, Stuart Ashman.
The FTSE 100 closed the week down 0.6% after data from the Office for National Statistics showed the UK economy contracted by 0.1%. European markets also finished in negative territory,
FTSE 100 ends the week in the red. London’s blue-chip index finished lower on Friday, slipping almost 0.5%. The FTSE 100 closed at 9,667 points, dragged down by weakness across several
SkinBioTherapeutics PLC (AIM: SBTX) has reported encouraging early trading momentum for its current financial year, with management guidance pointing towards 2026 results aligned with market expectations. The AIM-listed group forecasts
Anglesey Mining plc (AYM), the UK minerals development company, announced a number of updates in relation to its corporate and financial position as well as additions to its Board of Directors.
Bezant (BZT), the copper-gold exploration and resource development company, announced that it has entered into a conditional share purchase agreement to acquire a 90% shareholding in Namib Lead and Zinc Mining
SkinBioTherapeutics plc (AIM: SBTX), a life science group focused on skin health, has confirmed the final results of its WRAP Retail Offer, completing a broader £4.2 million fundraising effort at
SkinBioTherapeutics signs exclusive commercial agreement with Superdrug for AxisBiotix™ products in the UK Placing and Subscription to raise £4.1m to support Superdrug agreement; Proposed Retail Offer to existing shareholders of
Catenai (CTAI), the AIM quoted provider of digital media and technology, announced that Alludium Ltd will be hosting an in-person ‘First Look’ event in London on 3 July 2025.
(Alliance News) – London’s FTSE 100 is called to open lower on Wednesday following the announcement of new further US tariffs on China, and global markets brace themselves for further turmoil.
Assisted Living / Dying There is a degree irony in the timing of the government’s assisted dying legislation this week. Firstly, that amongst all its ever grow issues, immigration, taxation,
Blencowe Resources (BRES), the London listed graphite company advancing the 100% owned Orom-Cross Graphite Project in Uganda provided a Q&A session. This follows the recent £1.6 million capital raise to fund